Literature DB >> 26991505

Changing pattern of dengue virus serotypes circulating during 2008-2012 and reappearance of dengue serotype 3 may cause outbreak in Kolkata, India.

Kallol Saha1, Monika Ghosh1, Rushna Firdaus1, Aritra Biswas1, Bikash Seth2, Debojyoti Bhattacharya3, Kheya Mukherjee4, Provash Chandra Sadhukhan1.   

Abstract

Dengue virus infection is a major cause of morbidity within the endemic tropical and subtropical regions of the world. Dengue virus has four distinct serotypes with specific clinical manifestations. In this study, we observed the changing pattern of dengue serotypes, age-wise dengue infection and useful sero-detection methods needed in a dengue endemic region. We identified dengue serotypes during a period of 5 years among patients with dengue symptoms visiting one of the largest tertiary care infectious disease hospitals of eastern India in Kolkata. A total of 433 dengue RNA positive samples were isolated from 712 acute dengue suspected cases. Age wise distribution highlighted the susceptible age group being >21 years (24.02%) followed by 11-15 years (21.71%) and 5-10 years (21.02%) of the total infected population. Higher numbers of infected cases were found within females as they are involved in more indoor works. The period of study experienced two dengue outbreaks one in 2008 and another in 2012. For early dengue detection, NS1 was found to be more confirmatory than IgM ELISA regarding sensitivity and specificity. DENV-1, 2, and 4 serotypes were the common circulating strains from 2008 until 2010, after which DENV-3 serotype infections rise and led to a massive dengue outbreak in Kolkata with increased numbers of DHF and DSS cases in 2012. The finding within our study emphasizes the public health importance of such prospective surveillance programs with respect to the changing dengue viral etiology and serotypes. J. Med. Virol. 88:1697-1702, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  NS1; RT-PCR; dengue haemorrhagic fever; dengue serotype; dengue shock syndrome; surveillance programme

Mesh:

Substances:

Year:  2016        PMID: 26991505     DOI: 10.1002/jmv.24529

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Spatio-temporal distribution analysis of circulating genotypes of dengue virus type 1 in western and southern states of India by a one-step real-time RT-PCR assay.

Authors:  K Alagarasu; J A Patil; M B Kakade; A M More; M Bote; D Chowdhury; M Seervi; N T Rajesh; M Ashok; B Anukumar; A M Abraham; D Parashar; P S Shah
Journal:  Infect Genet Evol       Date:  2019-07-31       Impact factor: 3.342

2.  Co-circulation of all the four dengue virus serotypes and detection of a novel clade of DENV-4 (genotype I) virus in Pune, India during 2016 season.

Authors:  Shubham Shrivastava; Divya Tiraki; Arundhati Diwan; Sanjay K Lalwani; Meera Modak; Akhilesh Chandra Mishra; Vidya A Arankalle
Journal:  PLoS One       Date:  2018-02-22       Impact factor: 3.240

3.  Evidence of dengue and chikungunya virus co-infection and circulation of multiple dengue serotypes in a recent Indian outbreak.

Authors:  S Mukherjee; S K Dutta; S Sengupta; A Tripathi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-29       Impact factor: 5.103

4.  The prevalence of dengue virus serotypes in asymptomatic blood donors reveals the emergence of serotype 4 in Saudi Arabia.

Authors:  Ahmed Mohamed Ashshi
Journal:  Virol J       Date:  2017-06-09       Impact factor: 4.099

5.  Viral Parkinsonism: An underdiagnosed neurological complication of Dengue virus infection.

Authors:  Hannah K Hopkins; Elizabeth M Traverse; Kelli L Barr
Journal:  PLoS Negl Trop Dis       Date:  2022-02-09

6.  Clinical and epidemiologic characteristics associated with dengue fever in Mombasa, Kenya.

Authors:  Jacqueline Kyungah Lim; Sultani Hadley Matendechero; Neal Alexander; Jung-Seok Lee; Kang Sung Lee; Suk Namkung; Esther Andia; Noah Oyembo; Sl-Ki Lim; Henry Kanyi; So Hee Bae; Jae Seung Yang; Mary A Ochola; Tansy Edwards; In-Kyu Yoon; Sammy M Njenga
Journal:  Int J Infect Dis       Date:  2020-09-03       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.